Medgenics (MDGN -7.3%) slips after pricing its offering of company stock and warrants at $5.25, near current levels. The company says it's bundling the shares and warrants together, with each unit sold at $5.25 consisting of one share of common stock and a warrant to purchase one-half of a share at an initial exercise price of $6.78. The medical technology and therapeutics company said it plans to sell 5.6M shares of stock in order to raise around $29.4M. Maxim Group is acting as sole book-running manager.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs